Everlywell is a digital health company pioneering the next generation of biomarker intelligence—combining AI-powered technology with human insight to deliver personalized, actionable health answers. We transform complex biomarker data into life-changing insights, seamlessly integrating advanced diagnostics, virtual care, and patient engagement to reshape how and where health happens.
Over the past decade, Everlywell has delivered close to 1 billion personalized health insights, transforming care for 60 million people and powering hundreds of enterprise partners including 8 of the top 10 largest health plans in the U.S. From chronic condition management to preventive screening, our customizable remote-based solution helps close critical care gaps and deliver measurable health outcomes at scale. Backed by a nationwide clinical network, integrated lab, and AI-powered platform, Everlywell enables seamless, at-home care that meets today's needs and leads the way into tomorrow's healthcare.
The Microbiome Labs™ story: from pioneers to trailblazers
2004
Visionary research microbiologist Kiran Krishnan discovers the innovation of spore-based probiotics. Coincidentally, integrative medicine leader Dr. Tom Bayne hears his patients say “Probiotics don’t work.” A shared vision sparked their partnership.
2012
Krishnan and Bayne establish Microbiome Labs™, intending to transform gut health through microbiome science and clinical insight.
2013
Krishnan and Bayne launch MegaSporeBiotic™, the first all-spore probiotic—redefining probiotic capability and efficacy.
2013 to 2021
10 clinical studies on MegaSporeBiotic™ are completed and published in peer-reviewed journals.
2021
Microbiome Labs™ joins Novozyme OneHealth, expanding its global reach and impact.
2024
As part of global biosolutions innovators Novonesis, Microbiome Labs™ scales its mission worldwide, empowering a new era of microbiome-centered health.
Seed Health is a microbiome science company pioneering applications of microbes for human and planetary health. In collaboration with leading academic researchers, we advance breakthrough discoveries in microbial sciences across a pipeline of novel therapeutics, consumer health innovations and environmental solutions. All consumer innovations in probiotics are commercialized under Seed®.